Royal Bank of Canada »

Bioxcel Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.5k 1.4k 3.11
2023-12-31 $18k 6.7k 2.73
2023-09-30 $6.1k 3.1k 2.00
2023-06-30 $14k 1.9k 7.14
2022-12-31 $0 2.7k 0.00
2022-09-30 $9.0k 752 11.95
2021-06-30 $175k 6.0k 29.12
2021-03-31 $323k 7.4k 43.67
2020-12-31 $269k 5.7k 46.96
2020-09-30 $124k 2.9k 43.33
2020-06-30 $67k 1.3k 53.09
2020-03-31 $999 41 24.39
2019-12-31 $6.0k 412 14.56
2019-09-30 $0 2 0.00
2018-09-30 $0 13 0.00
2018-03-31 $25k 2.4k 10.42